FeesSafety
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

F.N.B. Corporation Common Stock (FNB) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Nova Klúbburinn completes share buyback, purchasing 122.7 million shares at ISK 3.26 each

Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...

Market News
1 hour ago
Na
Neutral
Nova Klúbburinn completes share buyback, purchasing 122.7 million shares at ISK 3.26 each

Investors in NVE Corporation urged to join class action over alleged misleading info

The Rosen Law Firm has announced an investigation into potential securities claims against NVE Corporation, alleging the company provided misleading business information to investors. Shareholders who purchased NVE securities may be eligible for comp...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Investors in NVE Corporation urged to join class action over alleged misleading info

Visium Technologies cancels reverse stock split, commits to independent board and financial review

Visium Technologies announced the resignation of its CEO and a leadership transition with CFO Mark B. Lucky as interim CEO and sole director. The company rescinded a proposed 1-for-1,500 reverse stock split that would have eliminated small shareholde...

Market News
5 hours ago
GlobeNewsWire
Neutral
Visium Technologies cancels reverse stock split, commits to independent board and financial review

Law firm investigates FMC Corporation over possible securities fraud after sharp stock drop.

Pomerantz LLP is investigating FMC Corporation and some of its executives for potential securities fraud following the company's announcement of significantly lowered Q3 2026 revenue and EBITDA expectations. FMC's updated guidance revealed a revenue ...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Law firm investigates FMC Corporation over possible securities fraud after sharp stock drop.

Investigation launched into Integra LifeSciences over revenue miss and operational issues after flooding.

Pomerantz LLP is investigating Integra LifeSciences for potential securities fraud following the company's revenue guidance cut and operational disruptions caused by severe flooding at its Cincinnati facility. Integra's stock dropped significantly af...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Investigation launched into Integra LifeSciences over revenue miss and operational issues after flooding.

Law firm probes Greenland Energy for alleged securities fraud after stock plunge.

Pomerantz LLP is investigating Greenland Energy Company for potential securities fraud following a sharp stock price drop triggered by a critical report from Fugazi Research. The report accused Greenland Energy of overstating its oil reserves and hav...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Law firm probes Greenland Energy for alleged securities fraud after stock plunge.

DaVita faces securities fraud investigation after kidney care reform plan hits its stock.

Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a significant stock price drop triggered by a new federal kidney care strategy announced by the U.S. Department of Health and Human Services. The plan aims to increas...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
DaVita faces securities fraud investigation after kidney care reform plan hits its stock.

3M commits $5.8B through 2034 to settle PFAS injury claims, cutting litigation risks significantly.

3M has agreed to a $7.35 billion nominal settlement, with a present value of $5.8 billion, to resolve approximately 99% of PFAS-related personal injury claims involving up to 120,000 plaintiffs. This settlement reduces litigation uncertainty and alig...

Market News
5 hours ago
PRNewsWire
Neutral
3M commits $5.8B through 2034 to settle PFAS injury claims, cutting litigation risks significantly.

Neogen faces investigation after FDA links its sterile product to horse deaths, causing stock to drop 7%.

Pomerantz LLP is investigating Neogen Corporation following an FDA warning about its veterinary wound care product, Neogen Vet HYCOAT, which was linked to serious infections and at least 20 horse deaths. This represents the largest number of horse de...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Neogen faces investigation after FDA links its sterile product to horse deaths, causing stock to drop 7%.

Law firm probes Evolus over FDA warning on misleading Jeuveau ads, shares drop 7%.

Pomerantz LLP is investigating claims against Evolus, Inc. following an FDA warning about misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the ads for minimizing safety risks and making exaggerated claims about th...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Law firm probes Evolus over FDA warning on misleading Jeuveau ads, shares drop 7%.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $6.51B
  • Volume
    6,297,570
  • Sector
    Financials
  • 52W High
    $19.49
  • 52W Low
    $15.38
  • Typical Hold Time
    20 Days
  • Enterprise Value
    $10.90B
  • Div Yield
    2.82%
  • Trading Activity
    -
$18.3
52W Low: $15.38
17 Nov 2025
52W High: $19.49
16 Jul 2026

Track F.N.B. Corporation Common Stock (FNB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, F.N.B. Corporation Common Stock has traded between a low of $15.38 and a high of $19.49, highlighting its annual price range. Buy and sell F.N.B. Corporation Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!